Speclor SA. / Spector SA. / Roche Laboratories / Boehringerkgelheim Ben Venue Laboratories Ben Venue Laboratories / Ganciclovir Sodium Injection Ben Venue Laboratoires Inc. / Applicable Ganciclovir Sodium Injection Ben Venue Laboratpires Inc. / Ames / IT iS CO / Santarus Inc. / SupervisorRegulatory Affairs Ben Venue Laboratories Inc. / Regulatory Affairs Ben Venue Laboratories Inc. / /
Country
United States / /
Currency
USD / / /
Event
FDA Phase / /
Facility
PLANT RECll / / /
IndustryTerm
pharmaceutical change / drug product / ganclcfovir nlr ~iomm~stereaoraffy mm food / reference product / proposed drug product / food / PREVENTION OF CMV DISEASE / proposed solution product / /
MedicalCondition
CMV DISEASE OTHER THAN MAINTENANCE TREATMENT OF dV RETINITIS / HIV / headache / XV disease / CLINICAL TOXICITY OF CYTOVENE AND CYTOVENE-IV INCLUOES GRANULOCYTOPENIA / MS / HIV InfectIon / tumors / disease / CMV DISEASE / AUC compamonl. for hmttomtm sarcoma / pain / megalovirw pulmonary mfection A / AIDS / retinitis / ANEMIA / /
National Institute of Health / OOSAGE AND ADMINISTRATION / Amenun Society of Horprtal Pharmactsts / WV CC / African Union / DOSAGE AND ADMINISTRATION / FDA / /
Person
Range Mean / / /
Position
clinical WB / Prime Minister / mp / rt / requestthe Commissioner / Supervisor / cao / Major / /
Product
zidovudine / TRAl / POSSlo! / Cytovene / AX / dapsone / Sterile Water / ZYTOVENE Capsule / SAFETY AND EFFICACY OF CVTOVENE CAPSULES / L-2 / Ganciclovir / Ganciclovir Sodium / dV / JD‘CY /